Growth Stalk Holdings Corporation
11991 North Highway 99
Seminole, Oklahoma 74868
Filed as SEC Correspondence
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Washington, D. C. 20549
Attn: Daniel Crawford
November 14, 2022
| Re: | Growth Stalk Holdings Corporation (the “Company”) |
Post Qualification Amendment No. 1 to Offering Statement on Form 1-A Filed on September 6, 2022
File No. 024-11847 SEC Comment Letter dated September 14, 2022 |
Dear Sir or Madam:
Please find below our responses to the Commission’s September 14, 2022 Comment Letter regarding the above-referenced Post Qualification Amendment Number 1 to the Company’s Offering Statement on Form 1-A. Growth Stalk Holdings Corp is referred to herein as the “Company”, “we”, or “us”.
Response to Comment 1
Form 1-A POS filed September 6, 2022
1-A: Item 2 Issuer Eligibility, page 1
| 1. | Please be advised that the Company has filed all delinquent reports, specifically the Forms 10-Q for the periods ending March 31, 2022 (filed on November 7, 2022) and June 30, 2022 (filed on November 14, 2022). The Company respectfully requests that the Division of Corporation Finance proceed with its review of the Form 1-A POS. |
Please contact our securities counsel, Frederick M. Lehrer, at (561) 706-7646 or flehrer@securitiesattorney1.com should you have any questions regarding the foregoing maters.
Sincerely yours,
| By: | /s/ Joseph Babiak | |
| Joseph Babiak, Chief Executive Officer |
